1300 856 695
+44 203 514 0688
1800 867 1390If you would like to submit a blog post for consideration, please email admin@healthcert.com
Practice Review on Dermatology [January]
In the January practice review on dermatology, the TGA has issued a reminder to health professionals about the potential risks of psychiatric adverse effects associated with Roaccutane, while the Journal of the American Academy of Dermatology reports prescribing behaviour for oral antibiotics among United Kingdom GPs does not align with current acne guidelines, and exceeds recommended duration of therapy.
A Danish study identified a significant association between patients who have rosacea and their risk of having certain GI diseases, including coeliac disease, Crohn’s disease, ulcerative colitis, and irritable bowel syndrome. The Australian Institute of Health and Welfare’s latest report on skin cancer shows that while Australia still has the second-highest rate of melanoma in the world, rates are dropping among younger people. Looking at etanercept biosimilars, Brenzys® has been listed for chronic plaque psoriasis and PBAC has recommended an Authority Required listing of ixekizumab for severe chronic plaque psoriasis that is refractory to treatment with non-biological DMARDs.
Featured in this issue:
- TGA safety update for Roaccutane
- GP oral antibiotic prescribing practices for acne
- Link between rosacea and GI disorders
- Skin services review – Mohs surgery
- AIHW: Skin cancer in Australia report
- Brenzys® biosimilar of etanercept listed
- PBAC recommended listing Brenzys
- PBAC recommends ixekizumab for plaque psoriasis
- Post-market Review of biological DMARDs for plaque psoriasis
- Amendment to cosmetic surgery regulations
- Cannabis trial for melanoma
- Skin disease self-diagnosis
- Conferences
- Workshops, webinars and CPD
Click here to download the full paper
Interested in General Dermatology?
The HealthCert Professional Diploma of General Dermatology will teach you how to manage all major dermatological conditions in primary care. The courses are university quality-assured, CPD-accredited and count towards multiple Master degree pathways and clinical attachment programs in Australia and overseas. The program is delivered online.
1300 856 695
+44 203 514 0688
1800 867 1390
